Soleno Therapeutics Inc. buy The Goldman Sachs Group, Inc.
Start price
07.10.25
/
50%
€54.00
Target price
07.10.26
€106.85
Performance (%)
-33.07%
Price
16.01.26
€35.66
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Soleno Therapeutics Inc. is performing very badly with a performance of -33.07%. This prediction currently runs until 07.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | -3.045% | -3.045% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (NASDAQ:SLNO) was given a new $125.00 price target on by analysts at The Goldman Sachs Group, Inc.. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat